首页> 外文期刊>Cancer science. >Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front.
【24h】

Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front.

机译:肝细胞生长因子激活因子抑制剂1型(HAI-1)在入侵前沿癌细胞中的反常增强的免疫反应性。

获取原文
获取原文并翻译 | 示例
       

摘要

We have previously demonstrated significantly decreased immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1), an integral membrane protein that exhibits potent inhibitory activity against hepatocyte growth factor activator (HGFA) and matriptase, in colorectal adenocarcinomas. In this report, we describe further detailed analysis of HAI-1 expression in colorectal adenocarcinoma by using three kinds of anti-HAI-1 antibodies, each of which recognizes a distinct epitope of the HAI-1 molecule, and also by in-situ hybridization for HAI-1 mRNA. The results indicated that the decreased immunoreactivity of HAI-1 in colorectal carcinoma cells is largely a result of enhanced ectodomain shedding of HAI-1 in these cells. In contrast, immunoreactivity of mature membrane-form HAI-1 was paradoxically en-hanced in cancer cells at the invasion front, showing intense cell-stroma interactions and/or sprouting invasion. This finding indicates that these invading cells showed decreased ectodomain shedding of HAI-1 and consequently might require the existence of the membrane-form HAI-1. Of particular interest was the observation of a possible inverse correlation between paradoxical up-regulation of membrane-form HAI-1 expression and membrane-associated E-cadherin in these cells. These membrane-form HAI-1-positive sprouting cancer cells were also negative for MIB-1 immunohistochemically, indicating a low-proliferating population. All these results suggest that HAI-1 may mediate diverse functions in regard to the progression of colorectal carcinomas, and the immunoreactivity of membrane-form HAI-1 may serve as a marker of invading cancer cells.
机译:我们以前已经证明了肝细胞生长因子激活因子抑制剂1型(HAI-1)的免疫反应性显着降低,这是一种不可或缺的膜蛋白,在结直肠腺癌中表现出对肝细胞生长因子激活因子(HGFA)和脱氧核糖核酸酶的有效抑制活性。在本报告中,我们将通过使用三种抗HAI-1抗体(分别识别HAI-1分子的独特表位)以及通过原位杂交来描述大肠腺癌中HAI-1表达的进一步详细分析HAI-1 mRNA。结果表明,HAI-1在大肠癌细胞中的免疫反应性降低主要是由于这些细胞中HAI-1的胞外域脱落增强所致。相反,在入侵前沿的癌细胞中,成熟的膜状HAI-1的免疫反应性反常增强了,显示出强烈的细胞-基质相互作用和/或发芽侵袭。该发现表明这些侵袭细胞显示HAI-1的胞外域脱落减少,因此可能需要存在膜形式的HAI-1。特别令人感兴趣的是观察到这些细胞中膜形式HAI-1表达与膜相关E-钙粘蛋白的反常上调之间可能存在逆相关。这些膜形式的HAI-1阳性发芽癌细胞在免疫组化方面也对MIB-1呈阴性,表明种群数量低。所有这些结果表明,HAI-1可能介导大肠癌进展的多种功能,而膜形式HAI-1的免疫反应性可能是侵袭性癌细胞的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号